WEIKANG BIO-TECHNOLOGY GROUP COMPANY, INC. WARRANTWeikang Bio-Technology Group Co Inc • August 17th, 2009 • Pharmaceutical preparations • Nevada
WEIKANG BIO-TECHNOLOGY GROUP COMPANY, INC., a Nevada corporation (the "Company"), hereby certifies that, for value received, ARC China, Inc., a Shanghai corporation, or its registered assigns (the "Holder"), is entitled to purchase from the Company up to a total of 2,384,438 shares of common stock, par value $0.00001 per share (the "Common Stock"), of the Company (each such share, a "Warrant Share" and all such shares, the "Warrant Shares") at an exercise price equal to $2.75 per share (as adjusted from time to time as provided in Section 9, the "Exercise Price"), at any time and from time to time after the date hereof through and including the three-year anniversary of the date hereof (the "Expiration Date"), and subject to the terms and conditions set forth herein. This Warrant (this "Warrant") is issued pursuant to the Securities Purchase Agreement dated as of the date hereof by and among the Company, the Holder, and Corporate Stock Transfer, Inc., as escrow agent (the "Purchase Agr
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 17th, 2009 • Weikang Bio-Technology Group Co Inc • Pharmaceutical preparations • Nevada
This Registration Rights Agreement (the "Agreement") is made as of August 11, 2009 by and between Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), and ARC China, Inc., a Shanghai corporation (the "Investor"), pursuant to a Securities Purchase Agreement dated as of the date hereof by and among the Company, the Investor and Corporate Stock Transfer, Inc., as escrow agent (the "Securities Purchase Agreement"). Capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Securities Purchase Agreement.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2009 • Weikang Bio-Technology Group Co Inc • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this "Agreement") is dated as of August 11, 2009 by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), ARC China, Inc., a Shanghai corporation (the "Purchaser"), and for purposes of Sections 2.1(b) and 2.1(c) only, Corporate Stock Transfer, Inc. (the “Escrow Agent”).
